| Title | Author(s) | Year | View Count |
 | SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. | Jaume, M; Yip, MS; Kam, YW; Cheung, CY; Kien, F; Roberts, A; Li, PH; Dutry, I; Escriou, N; Daeron, M; Bruzzone, R; Subbarao, K; Peiris, JS; Nal, B; Altmeyer, R | 2012 | 57 |
 | Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fcγr pathway | Jaume, M; Yip, MS; Cheung, CY; Leung, HL; Li, PH; Kien, F; Dutry, I; Callendret, B; Escriou, N; Altmeyer, R; Nal, B; Daëron, M; Bruzzone, R; Peiris, JSM | 2011 | 152 |
| The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles | Siu, YL; Teoh, KT; Lo, J; Chan, CM; Kien, F; Escriou, N; Tsao, SW; Nicholls, JM; Altmeyer, R; Peiris, JSM; Bruzzone, R; Nal, B | 2008 | 198 |
| Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E | Nal, B; Chan, C; Kien, F; Siu, L; Tse, J; Chu, K; Kam, J; Staropoli, I; CrescenzoChaigne, B; Escriou, N; van der Wef, S; Yuen, KY; Altmeyer, R | 2005 | 269 |
| Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome | Kuiken, T; Fouchier, RAM; Schutten, M; Rimmelzwaan, GF; Van Amerongen, G; Van Riel, D; Laman, JD; De Jong, T; Van Doornum, G; Lim, W; Ling, AE; Chan, PKS; Tam, JS; Zambon, MC; Gopal, R; Drosten, C; Van Der Werf, S; Escriou, N; Manuguerra, JC; Stöhr, K; Peiris, JSM; Osterhaus, ADME | 2003 | 105 |
|
